Literature DB >> 9647450

Review of the effectiveness of capsaicin for painful cutaneous disorders and neural dysfunction.

M Hautkappe1, M F Roizen, A Toledano, S Roth, J A Jeffries, A M Ostermeier.   

Abstract

BACKGROUND: Topical capsaicin is known to be a safe and effective pain management adjunct for rheumatoid arthritis, osteoarthritis, neuralgias, and diabetic neuropathy. However, studies and case reports in the literature have indicated that other conditions may also benefit from capsaicin: painful or itching cutaneous disorders from operations, injuries, or tumors; neural dysfunction; or inflammation of the airways and urinary tract.
METHODS: To determine the effectiveness of capsaicin for painful cutaneous disorders and neural dysfunction, the authors analyzed data from 33 reports (MEDLINE search of 1966-96) on the efficacy of capsaicin. Outcome measures consisted of the response rate and degree of pain relief. Results from placebo-controlled trials were pooled when possible; effect of treatment was estimated by the method of DerSimonian and Laird.
RESULTS: Pain relief for postmastectomy syndrome and cluster headache was greater with capsaicin than with placebo; also, psoriasis and pruritus responded better to capsaicin. Uncontrolled studies and case reports have indicated that pain or dysfunction was less at the end of capsaicin therapy for neck pain, loin pain/hematuria syndrome, oral mucositis, rhinopathy, reflex sympathetic dystrophy syndrome, detrusor hyperreflexia, and cutaneous pain due to tumor of the skin.
CONCLUSIONS: Capsaicin is effective for psoriasis, pruritus, and cluster headache; it is often helpful for the itching and pain of postmastectomy pain syndrome, oral mucositis, cutaneous allergy, loin pain/hematuria syndrome, neck pain, amputation stump pain, and skin tumor; and it may be beneficial for neural dysfunction (detrusor hyperreflexia, reflex sympathetic dystrophy, and rhinopathy). A universal problem for many of the studies analyzed was the absence of a "burning placebo" such as camphor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9647450     DOI: 10.1097/00002508-199806000-00003

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  11 in total

1.  Civamide (cis-capsaicin) for treatment of primary or recurrent experimental genital herpes.

Authors:  N Bourne; D I Bernstein; L R Stanberry
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

Review 2.  Toxic phytochemicals and their potential risks for human cancer.

Authors:  Ann M Bode; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2014-10-27

3.  TRPV1-dependent and -independent alterations in the limbic cortex of neuropathic mice: impact on glial caspases and pain perception.

Authors:  Catia Giordano; Luigia Cristino; Livio Luongo; Dario Siniscalco; Stefania Petrosino; Fabiana Piscitelli; Ida Marabese; Luisa Gatta; Francesca Rossi; Roberta Imperatore; Enza Palazzo; Vito de Novellis; Vincenzo Di Marzo; Sabatino Maione
Journal:  Cereb Cortex       Date:  2011-12-01       Impact factor: 5.357

Review 4.  Molecular biology of capsaicinoid biosynthesis in chili pepper (Capsicum spp.).

Authors:  Cesar Aza-González; Hector G Núñez-Palenius; Neftalí Ochoa-Alejo
Journal:  Plant Cell Rep       Date:  2010-12-14       Impact factor: 4.570

Review 5.  The thermo-TRP ion channel family: properties and therapeutic implications.

Authors:  Laura Vay; Chunjing Gu; Peter A McNaughton
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

6.  Topical capsaicin--a novel and effective treatment for idiopathic intractable pruritus ani: a randomised, placebo controlled, crossover study.

Authors:  J Lysy; M Sistiery-Ittah; Y Israelit; A Shmueli; N Strauss-Liviatan; V Mindrul; D Keret; E Goldin
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

7.  The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats.

Authors:  Vito de Novellis; Daniela Vita; Luisa Gatta; Livio Luongo; Giulia Bellini; Maria De Chiaro; Ida Marabese; Dario Siniscalco; Serena Boccella; Fabiana Piscitelli; Vincenzo Di Marzo; Enza Palazzo; Francesco Rossi; Sabatino Maione
Journal:  Mol Pain       Date:  2011-01-17       Impact factor: 3.395

Review 8.  Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch.

Authors:  P Anand; K Bley
Journal:  Br J Anaesth       Date:  2011-08-17       Impact factor: 9.166

9.  Therapeutic potential of targeting MKK3-p38 axis with Capsaicin for Nasopharyngeal Carcinoma.

Authors:  Chengyao Chiang; Min Zhang; Dian Wang; Tian Xiao; Lizhi Zhu; Kai Chen; Junrong Huang; Jingying Huang; Jiang Zhu; Li Li; Cheng Chen; Yangchao Chen; Hongyi Hu; Wenqi Jiang; Yongdong Zou; Ting Wang; Duo Zheng
Journal:  Theranostics       Date:  2020-06-24       Impact factor: 11.556

10.  Development of a HPLC Method for the Quantitative Determination of Capsaicin in Collagen Sponge.

Authors:  Chun-Lian Guo; Hong-Ying Chen; Bi-Ling Cui; Yu-Huan Chen; Yan-Fang Zhou; Xin-Sheng Peng; Qin Wang
Journal:  Int J Anal Chem       Date:  2015-11-03       Impact factor: 1.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.